Gilead – Liver Disease Request for Proposal (RFP) Programs: STAT Program 2019
27/05/2019 09:46
Objetivo: Gilead actively supports investigator-sponsored research conducted by third parties on Gilead’s marketed products or within therapeutic areas of interest to the company. This research can provide valuable information regarding the safety, efficacy, pharmacology, and tolerability of Gilead’s products and supplement the comprehensive data generated in registration studies.
Inscrições: até 30 de junho de 2019
Mais informações no site.
